Drug Shortage Report for PMS-TERAZOSIN

Last updated on 2018-04-19 History
Report ID 32154
Drug Identification Number 02243518
Brand name PMS-TERAZOSIN
Common or Proper name TERAZOSIN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) TERAZOSIN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-08
Estimated end date 2018-04-30
Actual end date 2018-04-17
Shortage status Resolved
Updated date 2018-04-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-04-19 French Compare
v6 2018-04-19 English Compare
v5 2018-03-19 French Compare
v4 2018-03-19 English Compare
v3 2017-12-09 English Compare
v2 2017-12-08 French Compare
v1 2017-12-08 English Compare

Showing 1 to 7 of 7